Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

Recruiting Observational Study
Colorectal Cancer Colon Cancer Rectal Cancer Colorectal Adenocarcinoma Colorectal Neoplasms Malignant Rectal Adenocarcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
Immanuel Kant Baltic Federal University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histologically proven primary adenocarcinoma of bowel; * All patients who have indications for surgical treatment of colorectal cancer based on the decision of the oncological council; * Signed informed consent with agreement to attend all study visits; Exclusion Criteria: *…
Contacts

Tatiana N Garmanova, PhD

+79773429249

tatianagarmanova@gmail.com

CONTACT